These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38704915)

  • 1. The EPRS-ATF4-COLI pathway axis is a potential target for anaplastic thyroid carcinoma therapy.
    Mi L; Liu J; Zhang Y; Su A; Tang M; Xing Z; He T; Wei T; Li Z; Wu W
    Phytomedicine; 2024 Jul; 129():155670. PubMed ID: 38704915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ellagic acid inhibits cell proliferation, migration, and invasion of anaplastic thyroid cancer cells via the Wnt/β-catenin and PI3K/Akt pathways.
    Meng X; Cui Z; Shi H; Ma X; Li W; Liu X; Jiang Y
    Acta Biochim Pol; 2023 Feb; 70(1):109-115. PubMed ID: 36773307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PFKFB3 facilitates cell proliferation and migration in anaplastic thyroid carcinoma via the WNT/β-catenin signaling pathway.
    Deng J; Cheng Y; Li H; He X; Yu S; Ma J; Li X; Chen J; Xiao H; Guan H; Li Y
    Endocrine; 2024 Aug; 85(2):737-750. PubMed ID: 38378893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torin2 targets dysregulated pathways in anaplastic thyroid cancer and inhibits tumor growth and metastasis.
    Sadowski SM; Boufraqech M; Zhang L; Mehta A; Kapur P; Zhang Y; Li Z; Shen M; Kebebew E
    Oncotarget; 2015 Jul; 6(20):18038-49. PubMed ID: 25945839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PP121, a dual inhibitor of tyrosine and phosphoinositide kinases, inhibits anaplastic thyroid carcinoma cell proliferation and migration.
    Che HY; Guo HY; Si XW; You QY; Lou WY
    Tumour Biol; 2014 Sep; 35(9):8659-64. PubMed ID: 24867098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA NEAT1 enhances the resistance of anaplastic thyroid carcinoma cells to cisplatin by sponging miR‑9‑5p and regulating SPAG9 expression.
    Yan P; Su Z; Zhang Z; Gao T
    Int J Oncol; 2019 Nov; 55(5):988-1002. PubMed ID: 31485599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Krüppel-Like Factor 4 in the Maintenance of Chemoresistance of Anaplastic Thyroid Cancer.
    Lee SI; Kim DK; Seo EJ; Choi EJ; Kwon YW; Jang IH; Lee JC; Kim HY; Shong M; Kim JH; Kim SJ
    Thyroid; 2017 Nov; 27(11):1424-1432. PubMed ID: 28920531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alantolactone induces concurrent apoptosis and GSDME-dependent pyroptosis of anaplastic thyroid cancer through ROS mitochondria-dependent caspase pathway.
    Hu Y; Wen Q; Cai Y; Liu Y; Ma W; Li Q; Song F; Guo Y; Zhu L; Ge J; Zeng Q; Wang J; Yin C; Zheng G; Ge M
    Phytomedicine; 2023 Jan; 108():154528. PubMed ID: 36343549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apatinib Inhibits Angiogenesis Via Suppressing Akt/GSK3β/ANG Signaling Pathway in Anaplastic Thyroid Cancer.
    Jin Z; Cheng X; Feng H; Kuang J; Yang W; Peng C; Shen B; Qiu W
    Cell Physiol Biochem; 2017; 44(4):1471-1484. PubMed ID: 29190616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
    Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
    Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
    Wang Z; Qiu X; Zhang H; Li W
    J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HOXD9/miR-451a/PSMB8 axis is implicated in the regulation of cell proliferation and metastasis via PI3K/AKT signaling pathway in human anaplastic thyroid carcinoma.
    Zhong Y; Yu F; Yang L; Wang Y; Liu L; Jia C; Cai H; Yang J; Sheng S; Lv Z; Weng L; Wu B; Zhang X
    J Transl Med; 2023 Nov; 21(1):817. PubMed ID: 37974228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
    Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W
    Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
    Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo.
    Ferrari SM; Bocci G; Di Desidero T; Elia G; Ruffilli I; Ragusa F; Orlandi P; Paparo SR; Patrizio A; Piaggi S; La Motta C; Ulisse S; Baldini E; Materazzi G; Miccoli P; Antonelli A; Fallahi P
    Oncol Rep; 2018 May; 39(5):2225-2234. PubMed ID: 29517103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ophiopogonin D' inhibited tumour growth and metastasis of anaplastic thyroid cancer by modulating JUN/RGS4 signalling.
    Xu T; Zhang W; Zhang Y; Song F; Huang P
    J Cell Mol Med; 2024 Aug; 28(16):e70014. PubMed ID: 39153211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
    Tang J; Tian Z; Liao X; Wu G
    Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.
    Patel PN; Yu XM; Jaskula-Sztul R; Chen H
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(0 4):S497-504. PubMed ID: 24419754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
    Gao H; Wang W; Li Q
    Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking CDK7-Mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Doolittle WKL; Zhao L; Cheng SY
    Thyroid; 2022 Aug; 32(8):937-948. PubMed ID: 35822558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.